MARKET

PPCB

PPCB

Propanc Bio
NASDAQ
0.1898
-0.0121
-5.99%
After Hours: 0.1800 -0.0098 -5.16% 19:57 02/06 EST
OPEN
0.1900
PREV CLOSE
0.2019
HIGH
0.2000
LOW
0.1629
VOLUME
2.09M
TURNOVER
--
52 WEEK HIGH
11.00
52 WEEK LOW
0.1555
MARKET CAP
2.54M
P/E (TTM)
-0.0042
1D
5D
1M
3M
1Y
5Y
1D
Propanc Biopharma highlights potential of lead proenzyme therapy
TipRanks · 2d ago
Propanc Biopharma Highlights Potential Of Proenzyme Therapy, PRP, To Compete With Existing Approved Therapies For Solid Tumors
Benzinga · 2d ago
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
Barchart · 2d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 3d ago
Propanc Biopharma files to sell 7M shares of common stock for holders
TipRanks · 4d ago
Weekly Report: what happened at PPCB last week (0126-0130)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 01/29 17:05
Propanc Biopharma files fourth patent application with IP Australia
TipRanks · 01/27 13:50
More
About PPCB
Propanc Biopharma, Inc. is an Australia-based biopharmaceutical company. The Company is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.

Webull offers Propanc Biopharma Inc stock information, including NASDAQ: PPCB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PPCB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PPCB stock methods without spending real money on the virtual paper trading platform.